Aclaris Therapeutics Inc. (ACRS)
1.59
-0.03 (-1.85%)
At close: Mar 28, 2025, 3:17 PM
Aclaris Therapeutics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Cash & Equivalents | 24.57M | 39.88M | 45.28M | 27.35M | 54.13M | 35.94M | 57.02M | 208.85M | 30.17M | 9.85M | 10.76M | 9.59M |
| Short-Term Investments | 89.02M | 79.23M | 172.29M | 164.06M | 32.07M | 39.08M | 110.95M | 173.66M | 107.05M | 75.02M | 5.37M | 3.74M |
| Long-Term Investments | n/a | 62.77M | 12.24M | 34.24M | n/a | n/a | n/a | 15M | 36.91M | 7.17M | 518K | 802K |
| Other Long-Term Assets | 93.37M | 3.89M | -630K | 3.55M | 4.51M | 4.83M | 332K | 279K | -35.44M | -5.49M | 10K | n/a |
| Receivables | 318K | 298K | 484K | 623K | 772K | 704K | 563K | 481K | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | -12.24M | -34.24M | n/a | 4.97M | 791K | -6.36M | n/a | n/a | n/a | n/a |
| Other Current Assets | 12.04M | 9.45M | 13.49M | 25.99M | 5.18M | 9.83M | 10.17M | 9.77M | 2.67M | 3.1M | 204K | 62K |
| Total Current Assets | 125.95M | 128.86M | 231.55M | 205.03M | 57.49M | 83.8M | 179.5M | 208.85M | 174.13M | 92.04M | 16.33M | 13.39M |
| Property-Plant & Equipment | 1.01M | 1.62M | 1.1M | 1.33M | 1.65M | 2.47M | 4.28M | 2.16M | 481K | 360K | 515K | 19K |
| Goodwill & Intangibles | n/a | 269K | 6.97M | 7.05M | 7.12M | 7.2M | 91.45M | 25.85M | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 94.38M | 68.55M | 23.05M | 46.18M | 13.29M | 14.49M | 96.07M | 34.66M | 1.95M | 2.04M | 1.04M | 821K |
| Total Assets | 220.33M | 197.41M | 254.6M | 251.21M | 70.78M | 98.3M | 275.57M | 243.51M | 176.09M | 94.08M | 17.38M | 14.21M |
| Account Payables | 4.69M | 8.88M | 10.35M | 9.98M | 5.25M | 9.92M | 11.68M | 7.82M | 2.85M | 810K | 1.26M | 353K |
| Deferred Revenue | 3.89M | n/a | n/a | 10.05M | 5.91M | 7.72M | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | n/a | 426K | 1.37M | 1.39M | 1.21M | 1.27M | 142K | 142K | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 23.02M | 21.65M | 10.22M | 11.56M | 8.41M | 11.24M | 15.53M | 4.8M | 3.38M | 745K | 188K | 14K |
| Total Current Liabilities | 31.6M | 30.95M | 21.94M | 22.93M | 14.87M | 22.43M | 27.34M | 12.76M | 6.22M | 1.55M | 1.45M | 367K |
| Long-Term Debt | n/a | n/a | n/a | n/a | 10.65M | n/a | 29.91M | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 33.18M | 9.27M | 34.67M | 30.57M | 7.24M | 5.4M | 2.64M | 4.94M | 372K | n/a | 36.68M | 23M |
| Total Long-Term Liabilities | 33.18M | 9.27M | 35.04M | 30.94M | 18.26M | 5.95M | 33.1M | 5.49M | 372K | n/a | 36.68M | 23M |
| Total Liabilities | 64.77M | 40.23M | 56.98M | 53.87M | 33.13M | 28.39M | 60.44M | 18.25M | 6.59M | 1.55M | 38.13M | 23.37M |
| Total Debt | n/a | 426K | 684K | 693K | 11.26M | 637K | 30.52M | 142K | n/a | n/a | n/a | n/a |
| Common Stock | 1K | 1K | 1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Retained Earnings | -902.86M | -770.8M | -682.32M | -595.41M | -504.54M | -453.53M | -292.17M | -159.44M | -90.91M | -42.83M | -20.75M | -9.17M |
| Comprehensive Income | 97K | -106K | -897K | -224K | -94K | -66K | -69K | -246K | -269K | -149K | -6K | 3K |
| Shareholders Equity | 155.55M | 157.18M | 197.62M | 197.34M | 37.65M | 69.91M | 215.12M | 225.26M | 169.49M | 92.52M | -20.75M | -9.16M |
| Total Investments | 89.02M | 142M | 184.54M | 198.31M | 32.07M | 39.08M | 110.95M | 188.65M | 143.96M | 82.19M | 5.89M | 4.54M |